Determining the optimal SARS-CoV-2 mRNA vaccine dosing interval for maximum immunogenicity
M. Asamoah-Boaheng, D. M. Goldfarb, M. Prusinkiewicz…·B. Grunau
This study finds that longer SARS-CoV-2 vaccine dosing intervals (≥30 days) are associated with higher antibody concentrations and viral neutralization at 6 months post-first dose.